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Abstract
Intraductal papillary mucinous neoplasms (IPMN) of the pancreas are 
characterized by proliferation of mucin-secreting cells in the main 
pancreatic duct (PD) or its branches. The secreted thick mucin usu-
ally leads to PD obstruction and dilation. A common complication 
of IPMN is recurrent acute pancreatitis secondary to poor pancreatic 
fluid drainage, and rarely, pancreatobiliary and pancreatointestinal 
fistulae. We describe a unique case of IPMN in a 57-year-old male 
who was referred to our institution for evaluation of recurrent acute 
pancreatitis. After extensive evaluation, he was diagnosed with main 
duct IPMN. Intraductal PD biopsy revealed intestinal type IPMN with 
intermediate grade dysplasia. Patient was managed clinically by large 
caliber (10 French) PD stenting which eliminated his recurrent acute 
pancreatitis. The patient was initially referred for pancreatic resection; 
however, surgery was aborted and evaluated to be high risk with high 
morbidity secondary to the extensive adhesions between the pancreas 
and surrounding structures. Patient remained clinically stable for a 
few years except for an episode of acute pancreatitis that happened 
after a trial of stent removal. Subsequently, the patient did well af-
ter the PD stent was replaced. Recently, repeat abdominal imaging 
revealed a large pancreatoduodenal fistula which was confirmed on 
repeat endoscopic retrograde cholangiopancreatography. We were 
able to perform pancreatoscopy by advancing a regular upper scope 
through the fistula and into the PD. Interestingly, the fistula relieved 
the symptoms of obstruction and subsequently decreased the fre-
quency of recurrent pancreatitis episodes with no further episodes at 
6 months follow-up. This case highlights the importance of providing 
adequate PD drainage to reduce the frequency of recurrent acute pan-
creatitis in the setting of main duct IPMN, especially if the patient is 
not a surgical candidate. Also, physicians need to monitor for compli-
cations such as fistula formation between the pancreas and surround-
ing structures in the setting of chronic inflammation due to recurrent 
episodes of pancreatitis. Early identification of a fistula is important 
for surgical planning. Furthermore, since recent studies suggested a 
higher incidence of additional primary malignancies in patients with 
IPMN of the pancreas compared to the general population, patients 
may be considered for screening for other primary malignancies.
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Introduction
Intraductal papillary mucinous neoplasms (IPMN) of the pan-
creas are tumors that originate in the main pancreatic duct 
(PD), branch ducts, or both. They are characterized by intra-
ductal proliferation of mucin-secreting cells that leads to pan-
creatic ductal strictures/obstruction with resultant upstream di-
lation of the involved PD or branch. Detection of these lesions 
has increased over the past decade due to the widespread use of 
advanced abdominal imaging modalities which are performed 
for evaluation of pancreatic or non-pancreatic symptoms. A 
common complication of IPMN is recurrent episodes of acute 
pancreatitis due to pancreatic ductal obstruction/stricture with 
impairment of pancreatic fluid drainage [1]. Furthermore, there 
have been rare reports of pancreatobiliary and pancreatointes-
tinal fistulae associated with IPMN in the literature, and when 
reported, these cases are usually seen in the elderly population.
We present a unique case of IPMN complicated by large 
fistula formation between the pancreas and the small bowel in 
a middle-aged man with episodes of recurrent pancreatitis, in 
which the fistula relieved the symptoms of pancreatic ductal 
obstruction and subsequently decreased the frequency of the 
recurrent attacks of acute pancreatitis.
Case Report
A 57-year-old male with history of hypertension, gastroesopha-
geal reflux disease, prostate cancer status post total prostatec-
tomy, and type 2 diabetes mellitus presented for evaluation of 
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chronic pancreatitis and unintentional weight loss of 40 pounds 
over a 6-month period. The patient’s social history was signifi-
cant for alcohol use (three drinks per week) that he quit 5 years 
prior to presentation and chewing tobacco. Patient’s medica-
tions included pancrelipase 24,000 units twice daily, insulin de-
temir, omeprazole and losartan. His vital signs on presentation 
were remarkable for a blood pressure of 173/81 mm Hg. Physi-
cal examination was unremarkable except for a healed scar at 
the right upper quadrant. Three years prior to this presentation, 
the patient was diagnosed with acute pancreatitis which was 
thought to be secondary to gallstones and his initial course was 
complicated by a ruptured gallbladder which required open 
cholecystectomy. He subsequently developed five episodes of 
pancreatitis over the span of 6 months before presentation, with 
the frequency of recurrence increasing to every 3 - 4 weeks.
The patient underwent a magnetic resonance cholangio-
pancreatography (MRCP), which showed marked dilatation 
of the main PD with mild ductal irregularity and diffuse side 
branch dilatation, and the main PD was narrowed at the site of 
insertion into the duodenal papilla. There was also a mention 
of groove pancreatitis (pancreatitis affecting the groove be-
tween the pancreatic head, duodenum, and common bile duct) 
by visualization of wall thickening and cystic changes of the 
second portion of duodenum with surrounding inflammatory 
fat stranding. Therefore, endoscopic ultrasound (EUS) and en-
doscopic retrograde cholangiopancreatography (ERCP) were 
performed and revealed changes consistent with severe chronic 
pancreatitis classified as Cambridge grade 5, along with main 
PD dilation to 13 mm in diameter as well as irregularities and 
stricture in the mid body of pancreas. In addition, hyperecho-
ic strands and intraductal filling defects suggestive of stones 
were visualized and the common bile duct (CBD) was dilated 
up to 10 mm with mild narrowing in the head of the pancreas. 
Pancreatic and biliary sphincterotomies were performed and 
thick mucin, debris, and small stones were removed from the 
main PD. Brushing and biopsies were obtained from the PD 
stricture followed by placement of a plastic stent (10 French) 
in the main PD and another plastic ZSO 10-9 stent in the CBD. 
Histopathology examination revealed pancreatobiliary mucosa 
with chronic active inflammation and submucosal fibrosis and 
cytology revealed atypical cells favoring reactive changes.
Two weeks after the procedure, the patient developed an-
other flare of acute pancreatitis. He subsequently underwent 
five ERCP procedures over the span of 14 months with mul-
tiple exchanges of main PD and CBD stents and removal of 
stones, mucous, and debris. Further brushings and biopsies of 
the PD stricture were obtained. After the procedures, the pa-
tient reported subjective improvement of his symptoms and re-
mained for the most part symptoms free in between the ERCP 
procedures as long as the pancreatic stents had remained in 
place. Patient had few episodes of acute pancreatitis that were 
related either to migration or occlusion of the pancreatic stents. 
Subsequent biopsies revealed pancreatobiliary mucosa and 
low grade pancreatic intraepithelial neoplasia with papillary 
protrusion consistent with IPMN. The pathology specimen 
obtained during the last ERCP showed intestinal type IPMN 
with low grade dysplasia as well as areas of nuclear crowding, 
pseudostratification, and focal loss of polarity consistent with 
intermediate grade dysplasia (Fig. 1). There was no high-grade 
dysplasia or carcinoma identified.
Patient was subsequently referred to the hepatobiliary 
surgical team to be evaluated for surgical intervention. Tumor 
markers were sent and showed normal carbohydrate antigen 
(CA) 19-9 and alpha-fetoprotein (AFP) and elevated car-
cinoembryonic antigen (CEA) (5.8 ng/mL). Repeat MRCP 
showed one of the PD side branches extended anteriorly and 
abutted the gastric body with significant gastric wall thicken-
ing and surrounding inflammatory changes. Patient’s course 
was later complicated by hospitalization for another episode 
of acute pancreatitis with resultant formation of pancreatic ab-
Figure 1. This is a section of the pancreatic duct biopsy showing mucinous epithelium with a papillary architecture. The higher 
power view (inset) shows areas with nuclear hyperchromasia and crowding, consistent with intermediate grade dysplasia.
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scess which was communicating with the dilated main PD. He 
was treated with a 10-day course of ciprofloxacin and metro-
nidazole. Patient was initially scheduled for distal or total pan-
createctomy, but the surgery was delayed for 3 weeks to allow 
healing post hospitalization. Pre-operative computed tomog-
raphy scan of the abdomen and pelvis with intravenous (IV) 
contrast demonstrated a pancreaticoduodenal fistula from the 
pancreatic neck to the first portion of the duodenum along with 
peri-pancreatic inflammatory changes and persistent ductal 
dilatation (Fig. 2). In the setting of the extensive adhesions 
between the pancreas, stomach and transverse mesocolon mes-
entery, the surgical procedure was aborted intraoperatively and 
will not be pursued further due to the high morbidity involved 
in attempting the pancreatic resection.
He later underwent another ERCP procedure which re-
vealed a large pancreatoduodenal fistula at the bulb of the duo-
denum (Fig. 3). We were able to perform direct pancreatoscopy 
by advancing a therapeutic upper scope through the pancrea-
toduodenal fistula into the main PD. Diffuse villiform projec-
tions throughout the main PD consistent with main duct IPMN 
were visualized. The main PD was found to be diffusely dilated 
up to 22 mm and filled with thick mucus. Due to the good drain-
age of the PD through the fistula, we elected not to place a pan-
creatic stent. Patient remained clinically stable with no further 
episodes of recurrent acute pancreatitis for a few years.
Discussion
IPMN of the pancreas are mucinous tumors that originate in 
the main PD, branch duct or both [2]. Based on histological 
characteristics, they are divided into low, intermediate, high 
grade dysplasia and invasive carcinoma [3, 4]. Frequency of 
incidental pancreatic cyst detection is on the rise secondary to 
the widespread use of imaging modalities which are done for 
other purposes [5]. Recent studies have described that IPMN 
are detected in 80% of patients with incidental pancreatic cysts 
[6]. The presentation of such cysts ranges from an asympto-
matic incidentaloma [7] to a more severe clinical picture of 
acute pancreatitis manifesting as severe nausea, vomiting, and 
abdominal pain [8]. Once IPMN is suspected, specialized im-
aging modalities such as EUS and MRCP are performed to bet-
ter visualize and characterize the cyst for malignant potential. 
Pancreatic cystic lesions with dilatation of the PD or one of its 
branches along with intraductal filling defects accompanied by 
chronic pancreatitis changes are the most frequently encoun-
tered findings on imaging [9]. Therefore, one of the main com-
plications of IPMN is recurrent pancreatitis secondary to the 
obstruction of pancreatic fluid drainage.
Management of such neoplasms differs depending on the 
histologic classification and location. Literature has shown 
that branch duct IPMNs are less aggressive than their main 
duct counterparts for each given size [10, 11]. Surgery is rec-
ommended for all main-duct IPMN because of the higher ma-
lignant potential. In contrast, surgery for side-branch IPMN is 
performed only for lesions that are symptomatic with features 
suggestive of advanced stage or malignancy such as dilated 
main PD, mural nodules, or positive cytology. Thus, interna-
tional consensus guidelines for the treatment of branch duct 
IPMN were established to assist in decision making of pursu-
ing the surgical option of resection (Table 1) [12, 13] although 
controversy remains over the optimal management [14].
Although pancreatobiliary and pancreatointestinal fistulae 
associated with IPMN of the pancreas have been reported in the 
elderly population, no such cases have been reported in middle 
aged patients and there are no reports making the connection 
between formation of the fistulae and subsequent reduction in 
the frequency of recurrent acute pancreatitis. The average age 
of patients with fistula formation is the late seventh decade 
and early eighth decade with a predominance of female gen-
der [15]. Fistula formation is most common in the duodenum, 
Figure 2. A sidebranch pancreatic duct within the pancreatic neck com-
municating with the first portion of the duodenum. It measures 1.6 cm 
in transverse diameter and represents a pancreaticoduodenal fistula.
Figure 3. ERCP reveals the large pancreaticoduodenal fistula with 
contrast extravasation from the duodenum into the pancreatic duct.
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followed by the stomach, common bile duct, and colon [16]. 
Furthermore, malignant IPMNs are more likely to develop fis-
tulae. Patients with pancreatobiliary fistulae may present with 
obstructive jaundice and cholangitis which may be a result of 
one or combination of three potential mechanisms: direct ma-
lignant invasion of the IPMN, or mechanical compression by 
the cystic lesion in the head of the pancreas, or mucin impac-
tion within the lumen of the bile duct [14, 15]. Similarly, pan-
creatointestinal fistulae often result from mechanical pressure 
of the cystic lesion leading to erosion into the gastrointestinal 
lumen, or direct malignant invasion [14, 15].
Our case highlights two unique points. First, there exists 
limited literature describing the formation of the pancreati-
coduodenal fistula from the pancreatic neck to the first portion 
of the duodenum in the setting of IPMN. This fistula decreased 
the frequency of recurrent acute pancreatitis attacks secondary 
to providing a better drainage of the mucus and debris from 
the main PD. The patient was doing well at follow-up and de-
nied any further attacks. Taking into consideration the location 
of the pancreatitis, affecting the groove, the fistula likely oc-
curred in the setting of chronic peri-pancreatic inflammation. 
Review of the last MRCP further supports fistula formation, 
as it demonstrates one of the PD side branches abutting the 
gastric body with significant gastric wall thickening. Second, 
pancreaticoduodenal fistula formation complicates surgical 
planning. In this scenario, presence of the fistula increased the 
morbidity associated with the surgical treatment option due to 
significant adhesions between the pancreas and the surround-
ing organs. Future studies are needed to better characterize the 
optimal management of such cases.
Physicians need to maintain a high index of suspicion for 
complications of IPMN such as fistula formation between the 
pancreas and surrounding structures in the setting of chronic 
inflammatory changes due to recurrent episodes of pancrea-
titis. Early identification of a fistula is important to prevent 
premature referral for surgical resection since such cases may 
not be amenable to surgical resection. Furthermore, recent 
studies have also suggested a higher incidence of additional 
primary malignancies in patients with IPMN of the pancreas 
compared to the general population [17]. Commonly reported 
sites include colorectal, breast, prostate, urinary tract, and lung 
in order of decreasing incidence. Although this may not have 
implications in elderly patients, in which IPMN are common, 
patients who are middle-aged may require consideration for 
close screening for other primary malignancies.
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Table 1.  Summary of the International Consensus Guidelines and Multi-Institutional Study for the Treatment of Main Duct and 
Branch Duct IPMN
Management 2006 Sendai Consensus Guidelines 2012 Revision of Guidelines 2017 Multi-institutional study
Main duct Resect the main duct and mixed 
variant IPMNs as long as the patient 
is a good surgical candidate with 
a reasonable life expectancy.
Rest all surgically fit patients 
with main duct IPMN.
The presence of obstructive jaundice, 
lymphadenopathy, or pancreatitis had the 
greatest strength in predicting the presence 
of high grade dysplasia and invasive cancer.
Branch duct Asymptomatic: observation “Worrisome features”a, 
“low-risk features” as well 
as “high-risk stigmata”b 
are introduced.
Having multiple worrisome features was 
additive in predicting high grade dysplasia 
and invasive cancer, with each additional 
feature increasing the OR by 1.39.
Symptomatic: resection not only to 
alleviate the symptoms, but also because 
of a higher likelihood of malignancy.
More conservative approach: 
Branch duct IPMN of > 
3 cm without “high-risk 
stigmata” can be observed 
without immediate resection.
Individualize decision to treat based 
on patient preferences and willingness 
to undergo follow-up studies, and the 
availability of safe pancreatic resection.
aPancreatitis, cyst size > 3 cm, thickened or enhancing cyst wall, non-enhancing mural nodule, duct caliber change, pancreas atrophy, and main duct 
size between 5 - 9 mm is considered a “worrisome feature”. bMPD diameter of ≥ 10 mm is one of the “high-risk stigmata”.
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